vs
American Bitcoin Corp.（ABTC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
American Bitcoin Corp.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$118.0M vs $75.5M），American Bitcoin Corp.同比增速更快（151.5% vs 27.7%），过去两年American Bitcoin Corp.的营收复合增速更高（296.9% vs 31.3%）
美国比特币公司专注于比特币相关业务领域。比特币是首个去中心化加密货币，由化名为中本聪的匿名人士于2008年发布白皮书后诞生，2009年随着开源代码上线正式投入使用，问世以来对全球金融与数字货币领域都产生了极为深远的影响。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ABTC vs PBYI — 直观对比
营收规模更大
ABTC
是对方的1.6倍
$75.5M
营收增速更快
ABTC
高出123.8%
27.7%
两年增速更快
ABTC
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.0M | $75.5M |
| 净利润 | — | — |
| 毛利率 | 49.1% | 69.3% |
| 营业利润率 | -192.8% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 151.5% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.07 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTCPBYI
| Q4 25 | $118.0M | $75.5M | ||
| Q3 25 | $64.2M | $54.5M | ||
| Q2 25 | $1.4M | $52.4M | ||
| Q1 25 | $1.6M | $46.0M | ||
| Q4 24 | $46.9M | $59.1M | ||
| Q3 24 | $11.6M | $80.5M | ||
| Q2 24 | $5.5M | $47.1M | ||
| Q1 24 | $7.5M | $43.8M |
净利润ABTCPBYI
| Q4 25 | — | — | ||
| Q3 25 | $3.5M | $8.8M | ||
| Q2 25 | $3.4M | $5.9M | ||
| Q1 25 | $-100.6M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-576.0K | $20.3M | ||
| Q2 24 | $-61.1M | $-4.5M | ||
| Q1 24 | $230.4M | $-4.8M |
毛利率ABTCPBYI
| Q4 25 | 49.1% | 69.3% | ||
| Q3 25 | 56.0% | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | 57.9% | 76.4% | ||
| Q3 24 | 4.2% | 63.9% | ||
| Q2 24 | 31.0% | 77.4% | ||
| Q1 24 | 35.4% | 75.5% |
营业利润率ABTCPBYI
| Q4 25 | -192.8% | 22.7% | ||
| Q3 25 | 11.2% | 17.6% | ||
| Q2 25 | -162.1% | 12.7% | ||
| Q1 25 | -350.8% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | -87.8% | 27.4% | ||
| Q2 24 | -106.4% | -4.6% | ||
| Q1 24 | -20.8% | -5.3% |
净利率ABTCPBYI
| Q4 25 | — | — | ||
| Q3 25 | 5.4% | 16.2% | ||
| Q2 25 | 249.2% | 11.2% | ||
| Q1 25 | -6458.5% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -5.0% | 25.2% | ||
| Q2 24 | -1107.2% | -9.6% | ||
| Q1 24 | 3076.2% | -11.0% |
每股收益（稀释后）ABTCPBYI
| Q4 25 | $-0.07 | $0.26 | ||
| Q3 25 | $0.06 | $0.17 | ||
| Q2 25 | $-0.07 | $0.12 | ||
| Q1 25 | $-0.09 | $0.06 | ||
| Q4 24 | $1.10 | $0.40 | ||
| Q3 24 | $-0.15 | $0.41 | ||
| Q2 24 | $-0.10 | $-0.09 | ||
| Q1 24 | $-0.36 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $665.8M | $130.3M |
| 总资产 | $1.2B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ABTCPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | $750.0K | $96.0M | ||
| Q1 25 | $367.0K | $93.2M | ||
| Q4 24 | $850.0K | $101.0M | ||
| Q3 24 | $478.0K | $96.7M | ||
| Q2 24 | $1.4M | $96.8M | ||
| Q1 24 | $1.9M | $107.2M |
总债务ABTCPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ABTCPBYI
| Q4 25 | $665.8M | $130.3M | ||
| Q3 25 | $575.5M | $115.3M | ||
| Q2 25 | $339.7M | $104.7M | ||
| Q1 25 | $115.8M | $97.1M | ||
| Q4 24 | $1.0B | $92.1M | ||
| Q3 24 | $697.5M | $71.1M | ||
| Q2 24 | $614.3M | $48.5M | ||
| Q1 24 | $696.8M | $51.0M |
总资产ABTCPBYI
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.2B | $202.9M | ||
| Q2 25 | $6.2M | $194.9M | ||
| Q1 25 | $9.0M | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $7.5M | $220.7M | ||
| Q2 24 | $11.4M | $205.0M | ||
| Q1 24 | $17.8M | $214.1M |
负债/权益比ABTCPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-79.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ABTCPBYI
| Q4 25 | $-79.6M | $14.4M | ||
| Q3 25 | $-39.0M | $9.7M | ||
| Q2 25 | $-879.0K | $14.1M | ||
| Q1 25 | $-3.2M | $3.6M | ||
| Q4 24 | $-54.0M | $15.6M | ||
| Q3 24 | $-76.8M | $11.0M | ||
| Q2 24 | $201.0K | $1.0M | ||
| Q1 24 | $-983.0K | $11.2M |
自由现金流ABTCPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $-1.4M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-60.6M | $15.6M | ||
| Q3 24 | $-79.3M | $11.0M | ||
| Q2 24 | $-874.0K | $1.0M | ||
| Q1 24 | — | — |
自由现金流率ABTCPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | -104.4% | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | -129.2% | 26.4% | ||
| Q3 24 | -683.2% | 13.7% | ||
| Q2 24 | -15.8% | 2.1% | ||
| Q1 24 | — | — |
资本支出强度ABTCPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 40.5% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 14.1% | 0.0% | ||
| Q3 24 | 21.6% | 0.0% | ||
| Q2 24 | 19.5% | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率ABTCPBYI
| Q4 25 | — | — | ||
| Q3 25 | -11.21× | 1.10× | ||
| Q2 25 | -0.26× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
